Odyssean
Odyssean reported 485 stocks worth $615M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RARE (0.7%), KYMR (0.6%) and IDYA (0.6%). Compared with Q1 2026, the fund opened new positions in CLDX, DASH and MEDP, added to RARE, KYMR and IDYA, trimmed DELL and FTNT and sold out of REGN, NLY and CPT.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 3 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RARE Ultragenyx Pharmaceutical in | $4.1M | 0.7% | 122K | +55K (+81%) | 3 of 3 | |
| 2 |  KYMR Kymera Therapeutics Inc | $4M | 0.6% | 34K | +20K (+133%) | 3 of 3 | |
| 3 |  IDYA Ideaya Biosciences Inc | $3.8M | 0.6% | 103K | +87K (+572%) | 3 of 3 | |
| 4 |  PCVX Vaxcyte Inc | $3.6M | 0.6% | 63K | +43K (+211%) | 3 of 3 | |
| 5 |  AFRM Affirm Hldgs Inc | $3.6M | 0.6% | 44K | +26K (+139%) | 3 of 3 | |
| 6 |  CLDX Celldex Therapeutics Inc | $3.5M | 0.6% | 95K | New position | 1 of 3 | |
| 7 |  LOAR Loar Holdings Inc | $3.5M | 0.6% | 44K | +23K (+111%) | 3 of 3 | |
| 8 |  MIRM Mirum Pharmaceuticals Inc | $3.5M | 0.6% | 30K | +18K (+150%) | 3 of 3 | |
| 9 |  DASH Doordash Inc | $3.5M | 0.6% | 19K | New position | 2 of 3 | |
| 10 |  KRYS Krystal Biotech Inc | $3.5M | 0.6% | 9,349 | +4,530 (+94%) | 3 of 3 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 REGN Regeneron Pharmaceutical | $1.5M | 1,957 |
AIR LEASE CORP | $1.5M | 23K |
TRI POINTE HOMES INC | $1.5M | 32K |
MASIMO CORP | $1.4M | 7,845 |
 NLY Annaly Capital Management in | $1.4M | 65K |
🔒 Free account: see all 30.
Reported value
last 3 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Odyssean 13F FAQ
What does Odyssean own?
Odyssean reported 485 stocks worth $615M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RARE (0.7%), KYMR (0.6%) and IDYA (0.6%). The table above lists every position in the filing (the top 10 without an account).
What did Odyssean buy and sell in Q2 2026?
Compared with Q1 2026: 166 new positions, 189 added to, 29 trimmed and 99 sold out. New positions include CLDX, DASH and MEDP. It sold all of REGN, NLY and CPT.
When will Odyssean file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Odyssean's portfolio worth?
The Q2 2026 filing reports $615M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.